Variable | Hazard Ratio | 95% CI | P-value |
---|---|---|---|
Age (per SD) | 1.95 | 1.11–3.42 | 0.02 |
Female | 0.18 | 0.07–0.50 | 0.001 |
Hispanic ethnicity | 2.21 | 0.69–7.10 | 0.18 |
Former or active smoker | 1.37 | 0.51–3.65 | 0.53 |
Pulmonary hypertension | 2.32 | 0.86–6.25 | 0.10 |
FVC predicted, n (%) | |||
Mild(> 76.9%) | 1 (ref) | ||
Moderate(64.3–76.8%) | 0.55 | 0.09–3.29 | 0.51 |
Severe(< 64.2%) | 1.13 | 0.29–4.37 | 0.86 |
DLCo, predicted, n (%) | |||
Normal/Mild | 1 (ref) | ||
Moderate | 0.78 | 0.13–4.69 | 0.79 |
Severe | 2.45 | 0.59–10.27 | 0.22 |
NSIP ILD pattern | 0.47 | 0.13–1.66 | 0.24 |
UIP ILD pattern | 1.68 | 0.63–4.52 | 0.30 |
Immunosuppression | 1.08 | 0.31–3.78 | 0.91 |
Transplant referral | 2.12 | 0.67–6.70 | 0.20 |
CTD Subtype | |||
RA* | 2.05 | 0.76–5.52 | 0.16 |
Systemic Sclerosis | 1.20 | 0.34–4.24 | 0.77 |
Idiopathic Inflammatory Myositis | 1.08 | 0.31–3.84 | 0.90 |
Others (Spondylarthritis, ANCA vasculitis) | 4.22 | 0.94–18.96 | 0.06 |
SLE | 0.58 | 0.08–4.43 | 0.60 |